Australian and New Zealand Intensive Care Society Clinical Trials Group

The ANZICS Clinical Trials Group (CTG) is a world-leading investigator-led clinical trials network focused on improving outcomes for critically ill patients. Established in 1994, the group facilitates high-quality multicenter research across intensive care units in Australia and New Zealand. Their work encompasses a wide range of interventions, including pharmacological treatments, medical devices, and care delivery strategies for conditions such as sepsis, ARDS, and major trauma. The CTG is renowned for conducting large-scale, practice-changing Phase 3 trials that inform international clinical guidelines. By fostering collaboration between clinicians and researchers, the group ensures that intensive care practice is based on the highest quality evidence.